Laboratory Corp of America Holdings
Gesloten
SectorGezondheidszorg
255.92 -1.23
Overzicht
Wijziging aandelenprijs
24u
Min
254.31
Max
256.1
Inkomsten | 113M 278M |
|---|---|
Verkoop | 22M 3.5B |
K/W Sectorgemiddelde | 23.563 49.712 |
EPS | 4.25 |
Dividendrendement | 1.09 |
Winstmarge | 7.858 |
Werknemers | 71,000 |
EBITDA | 130M 548M |
Aanbevelingen | Strong Buy |
|---|---|
12 Maanden Prognose | +21.12% upside |
Dividendrendement Sectorgemiddelde | 1.09% 2.36% |
|---|---|
Volgende Winsten | 23 jul 2026 |
Volgende dividenddatum | 10 sep 2026 |
Volgende Ex Dividend datum | 27 aug 2026 |
Marktkapitalisatie | 108M 22B |
|---|---|
Vorige openingsprijs | 257.15 |
Vorige sluitingsprijs | 255.92 |
Nieuwssentiment
By Acuity
50%
50%
118 / 342 Rangschikking in Healthcare
Laboratory Corp of America Holdings Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Laboratory Corp of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.